The impact on thirty day readmissions for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease admitted to an observation unit versus an inpatient medical unit: A retrospective observational study

医学 观察研究 回顾性队列研究 急诊医学 肺栓塞 重症监护医学 内科学
作者
Jacob Bell,Steven Lim,Takahisa Mikami,JEEYUNE BAHK,S. Argirò,David Steiger
出处
期刊:Chronic Respiratory Disease [SAGE Publishing]
卷期号:21
标识
DOI:10.1177/14799731241242490
摘要

Objectives We aimed to evaluate the utility of an Observation Unit (OU) in management of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and to identify the clinical characteristics of patients readmitted within 30-days for AECOPD following index admission to the OU or inpatient floor from the OU. Methods This is a retrospective observational study of patients admitted from January to December 2017 for AECOPD to an OU in an urban-based tertiary care hospital. Primary outcome was rate of 30-day readmission after admission for AECOPD for patients discharged from the OU versus inpatient service after failing OU management. Regression analyses were used to define risk factors. Results 163 OU encounters from 92 unique patients were included. There was a lower readmission rate (33%) for patients converted from OU to inpatient care versus patients readmitted after direct discharge from the OU (44%). Patients with 30-day readmissions were more likely to be undomiciled, with history of congestive heart failure (CHF), pulmonary embolism (PE), or had previous admissions for AECOPD. Patients with >6 annual OU visits for AECOPD had higher rates of substance abuse, psychiatric diagnosis, and prior PE; when these patients were excluded, the 30-day readmission rate decreased to 13.5%. Conclusion Patients admitted for AECOPD with a history of PE, CHF, prior AECOPD admissions, and socioeconomic deprivation are at higher risk of readmission and should be prioritized for direct inpatient admission. Further prospective studies should be conducted to determine the clinical impact of this approach on readmission rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
michellewu完成签到,获得积分10
刚刚
王玥1266发布了新的文献求助30
刚刚
刚刚
香菜冲冲冲完成签到 ,获得积分10
刚刚
aoliao完成签到,获得积分10
刚刚
刚刚
shm123321完成签到,获得积分10
刚刚
刚刚
梅川秋裤完成签到,获得积分0
1秒前
可爱花瓣完成签到,获得积分10
1秒前
laoleigang完成签到,获得积分10
2秒前
zzzz完成签到 ,获得积分10
3秒前
fokuf完成签到 ,获得积分10
4秒前
粗犷的F完成签到,获得积分10
4秒前
Lincoln完成签到,获得积分10
4秒前
下文献发布了新的文献求助10
4秒前
ilk666完成签到,获得积分10
7秒前
1723完成签到,获得积分10
7秒前
吾身无拘发布了新的文献求助10
7秒前
顺利打开今日易开工完成签到,获得积分10
7秒前
炙热猎豹发布了新的文献求助10
7秒前
share完成签到 ,获得积分10
8秒前
千苏沐漓完成签到,获得积分10
8秒前
smottom完成签到,获得积分0
9秒前
小巧凝丹完成签到,获得积分10
9秒前
求助文献完成签到,获得积分10
10秒前
沟通亿心完成签到,获得积分10
12秒前
三石完成签到,获得积分10
12秒前
王先生完成签到,获得积分10
13秒前
科研黑洞完成签到,获得积分10
14秒前
14秒前
exile77完成签到,获得积分10
15秒前
开放灵竹完成签到,获得积分10
16秒前
炙热灵枫完成签到,获得积分10
17秒前
巴啦啦羊完成签到,获得积分10
17秒前
你好啊完成签到,获得积分10
17秒前
英俊的铭应助火星上白羊采纳,获得10
17秒前
刀客特咩完成签到 ,获得积分10
18秒前
20秒前
木仓发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362335
求助须知:如何正确求助?哪些是违规求助? 8176040
关于积分的说明 17224917
捐赠科研通 5417007
什么是DOI,文献DOI怎么找? 2866686
邀请新用户注册赠送积分活动 1843801
关于科研通互助平台的介绍 1691625